Skip to main content

Blackstone Inc.

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1393818 NEW YORK, NY

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,669,314
-$4,101,888 QoQ
Shares Held
120,177
-59.0% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#70
of 266 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Blackstone Inc. holds $252,665,757 across 52 Biotechnology names. SYRE ranks #10 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SYRE

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,669,314 120,177
2026-03-31 $14,771,202 292,847
2025-12-31 $16,412,694 500,998
2025-09-30 $8,396,726 500,998
2025-06-30 $7,324,042 489,248
2025-03-31 $7,894,016 489,248
2024-12-31 $10,457,399 449,201
2024-09-30 $8,616,982 292,995
2024-06-30 $6,888,312 292,995
2024-03-31 $758,258 19,991
2023-12-31 $430,206 19,991